Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion type Assertion NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_head.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion description "[Epidermal growth factor receptor (EGFR) gene mutations are associated with the sensitivity of non-small cell lung carcinomas (NSCLCs) to gefitinib, but such findings have not been reported in squamous cell carcinomas of the head and heck (SCCHNs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_provenance.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion evidence source_evidence_literature NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_provenance.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion SIO_000772 18097577 NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_provenance.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion wasDerivedFrom befree-2016 NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_provenance.
- NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_assertion wasGeneratedBy ECO_0000203 NP646625.RAWdXFJcYECwHu3ATSLk5xsMYntF1Lzww7tuAlq6SBvMs130_provenance.